Importance of secondary screening with clinical isolates for anti-leishmania drug discovery
出版年份 2018 全文链接
标题
Importance of secondary screening with clinical isolates for anti-leishmania drug discovery
作者
关键词
-
出版物
Scientific Reports
Volume 8, Issue 1, Pages -
出版商
Springer Nature America, Inc
发表日期
2018-07-31
DOI
10.1038/s41598-018-30040-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India
- (2017) Saumya Srivastava et al. Parasites & Vectors
- Exploiting Knowledge on Leishmania Drug Resistance to Support the Quest for New Drugs
- (2017) Aya Hefnawy et al. TRENDS IN PARASITOLOGY
- Unravelling the rate of action of hits in the Leishmania donovani box using standard drugs amphotericin B and miltefosine
- (2017) Diana Tegazzini et al. PLoS Neglected Tropical Diseases
- A ReplicativeIn VitroAssay for Drug Discovery against Leishmania donovani
- (2016) Diana Tegazzini et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective
- (2016) Om Prakash Singh et al. Infectious Diseases of Poverty
- New Compound Sets Identified from High Throughput Phenotypic Screening Against Three Kinetoplastid Parasites: An Open Resource
- (2015) Imanol Peña et al. Scientific Reports
- Development and Validation of a Novel Leishmania donovani Screening Cascade for High-Throughput Screening Using a Novel Axenic Assay with High Predictivity of Leishmanicidal Intracellular Activity
- (2015) Andrea Nühs et al. PLoS Neglected Tropical Diseases
- Comparison of Point-of-Care Tests for the Rapid Diagnosis of Visceral Leishmaniasis in East African Patients
- (2014) Asrat Bezuneh et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Comparison of a High-Throughput High-Content Intracellular Leishmania donovani Assay with an Axenic Amastigote Assay
- (2013) Manu De Rycker et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synthesis and biological evaluation of 2-aminothiazole derivatives as antimycobacterial and antiplasmodial agents
- (2013) Faith Mjambili et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Increasing Failure of Miltefosine in the Treatment of Kala-azar in Nepal and the Potential Role of Parasite Drug Resistance, Reinfection, or Noncompliance
- (2013) Suman Rijal et al. CLINICAL INFECTIOUS DISEASES
- Antimony-resistant but not antimony-sensitive Leishmania donovani up-regulates host IL-10 to overexpress multidrug-resistant protein 1
- (2013) B. Mukherjee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Comparison of Visceral Leishmaniasis Diagnostic Antigens in African and Asian Leishmania donovani Reveals Extensive Diversity and Region-specific Polymorphisms
- (2013) Tapan Bhattacharyya et al. PLoS Neglected Tropical Diseases
- Assessing the Essentiality of Leishmania donovani Nitroreductase and Its Role in Nitro Drug Activation
- (2012) S. Wyllie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Leishmaniasis Worldwide and Global Estimates of Its Incidence
- (2012) Jorge Alvar et al. PLoS One
- An Image-Based High-Content Screening Assay for Compounds Targeting Intracellular Leishmania donovani Amastigotes in Human Macrophages
- (2012) Jair L. Siqueira-Neto et al. PLoS Neglected Tropical Diseases
- Leishmania donovani Develops Resistance to Drug Combinations
- (2012) Raquel García-Hernández et al. PLoS Neglected Tropical Diseases
- Visceral leishmaniasis treatment: What do we have, what do we need and how to deliver it?
- (2012) Lucio H. Freitas-Junior et al. International Journal for Parasitology-Drugs and Drug Resistance
- Genome-wide SNP and microsatellite variation illuminate population-level epidemiology in the Leishmania donovani species complex
- (2011) Tim Downing et al. INFECTION GENETICS AND EVOLUTION
- Characterisation of antimony-resistant Leishmania donovani isolates: Biochemical and biophysical studies and interaction with host cells
- (2011) Rupkatha Mukhopadhyay et al. INTERNATIONAL JOURNAL FOR PARASITOLOGY
- A Screen against Leishmania Intracellular Amastigotes: Comparison to a Promastigote Screen and Identification of a Host Cell-Specific Hit
- (2011) Geraldine De Muylder et al. PLoS Neglected Tropical Diseases
- Linking In Vitro and In Vivo Survival of Clinical Leishmania donovani Strains
- (2010) Manu Vanaerschot et al. PLoS One
- Paromomycin for the Treatment of Visceral Leishmaniasis in Sudan: A Randomized, Open-Label, Dose-Finding Study
- (2010) Ahmed M. Musa et al. PLoS Neglected Tropical Diseases
- Cost-Effectiveness Analysis of Combination Therapies for Visceral Leishmaniasis in the Indian Subcontinent
- (2010) Filip Meheus et al. PLoS Neglected Tropical Diseases
- Antileishmanial High-Throughput Drug Screening Reveals Drug Candidates with New Scaffolds
- (2010) Jair L. Siqueira-Neto et al. PLoS Neglected Tropical Diseases
- In Vitro Susceptibilities of Leishmania donovani Promastigote and Amastigote Stages to Antileishmanial Reference Drugs: Practical Relevance of Stage-Specific Differences
- (2009) M. Vermeersch et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Sensitivity Testing of Leishmania Clinical Field Isolates: Preconditioning of Promastigotes Enhances Infectivity for Macrophage Host Cells
- (2009) R. Inocencio da Luz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Diagnostic tests for kala-azar: a multi-centre study of the freeze-dried DAT, rK39 strip test and KAtex in East Africa and the Indian subcontinent
- (2007) M. Boelaert et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started